Animal study · rats

BPC-157 sped blood flow recovery in rats with hind limb ischemia

Checked against the paper Animal studyPublished by PepVault

The takeaway

This paper adds rat and lab evidence that BPC-157 can boost blood vessel growth and blood flow recovery, but it is not a result in humans.

Kind
Animal study
Studied in
Rats
Published
2017
Journal
J Mol Med (Berl)

What they tested

The team set out to test whether BPC-157 helps new blood vessels form, and through which pathway it might work.

How the study was done

A preclinical study combining a chick chorioallantoic membrane test, a lab endothelial tube formation test, rats with hind limb ischemia (reduced blood flow to a hind leg), and lab-grown human vascular endothelial cells (cells that line blood vessels). Blood flow in the rats was tracked by laser Doppler scanning, and muscle tissue was checked under the microscope.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In rats with hind limb ischemia, BPC-157 made blood flow in the affected muscle recover faster, and the muscle held more vessels and more VEGFR2 (a receptor for a blood vessel growth factor). In the chick membrane test and in a lab endothelial tube formation test, a sign of new vessel growth, BPC-157 raised vessel density. In human vascular endothelial cells, it raised VEGFR2 at the mRNA and protein level but did not raise VEGF-A, and it drew VEGFR2 into the cell and switched on the VEGFR2-Akt-eNOS pathway over time. Dynasore, a drug that blocks endocytosis (the cell's uptake of material from its surface), stopped VEGFR2 from being drawn in, held back the pathway, and blocked the rise in tube formation.

What it doesn’t show

All results come from chick membranes, rats and lab-grown cells, so none of them show what BPC-157 does in people. The rat work looked at one type of leg blood flow injury and did not test other conditions.

The paper

Hsieh et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017.

The compound

More studies on BPC-157

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo